FAM91A1 Activators
FAM91A1 Activators are chemical compounds that influence various signaling pathways to increase the functional activity of FAM91A1. Forskolin, by activating adenylyl cyclase, leads to increased cAMP levels, which in turn activate PKA. PKA contributes to the phosphorylation of proteins interacting with FAM91A1, thus enhancing its function. IBMX, by inhibiting the breakdown of cAMP, leads to its accumulation, further potentiating the activation of PKA and subsequent enhancement of FAM91A1 activity. This mechanism demonstrates how increased cAMP levels, achieved through different means, can converge on the same downstream effect of FAM91A1 activation.
In addition to cAMP-mediated pathways, calcium-dependent mechanisms also play a significant role in the functional enhancement of FAM91A1. Ionomycin, Thapsigargin, and A23187 are examples of compounds that increase intracellular calcium levels. This rise in calcium can activate various calcium-dependent kinases and signaling molecules, which may impact FAM91A1 function. For instance, ionomycin acts as a calcium ionophore, directly increasing intracellular calcium, which then activates calmodulin-dependent kinases. These kinases can modulate the activity of proteins within FAM91A1's signaling network.Activation of protein kinase C (PKC) by compounds like Phorbol 12-myristate 13-acetate (PMA) adds another layer of regulatory control over FAM91A1's activity. PKC phosphorylates a range of substrates, some of which may interact with or regulate FAM91A1, leading to an enhancement of its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, preventing the breakdown of cAMP and cGMP and leading to their accumulation. Increased levels of these cyclic nucleotides augment PKA and PKG activity, thereby enhancing the activity of FAM91A1 through phosphorylation of its regulatory partners. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA. Activation of PKA leads to the phosphorylation of proteins that associate with FAM91A1, thus enhancing its functional activity by promoting its interactions with other cellular components. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to increased cAMP levels in certain cell types. Elevated cAMP positively influences PKA activity, which may phosphorylate proteins that modulate FAM91A1's function. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 activates G-protein-coupled receptors that signal through cAMP elevation. The subsequent activation of PKA or Epac could enhance FAM91A1 activity by modifying the phosphorylation state of proteins within its signaling pathway. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases such as JNK. JNK activation can result in the phosphorylation of substrates that modulate FAM91A1's activity, enhancing its functional role in the cell. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases PP1 and PP2A. By preventing the dephosphorylation of proteins, it can indirectly maintain the phosphorylated state of proteins that regulate or interact with FAM91A1, thus enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinases or other calcium-sensitive proteins that may influence FAM91A1's signaling network, leading to enhanced activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, which leads to an increase in cytosolic calcium levels. The subsequent activation of calcium-dependent signaling pathways can enhance FAM91A1 function by modulating proteins within its signaling network. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that raises intracellular calcium levels. The increase in calcium can stimulate calcium-dependent proteins or pathways that modulate FAM91A1's functional interactions, thereby enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator. The activation of PKC leads to the phosphorylation of proteins that are part of FAM91A1's signaling network, thus enhancing FAM91A1's activity through these protein-protein interactions. | ||||||